Found: 25
Select item for more details and to access through your institution.
Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Large‐Area, Stretchable, Textile‐Based Tactile Sensor.
- Published in:
- Advanced Materials Technologies, 2020, v. 5, n. 4, p. 1, doi. 10.1002/admt.201901060
- By:
- Publication type:
- Article
Does strategic coupling of TNCs affect their exit from host regions: Empirical analysis of the exit of Taiwanese enterprises from mainland China.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304254
- By:
- Publication type:
- Article
No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1736, doi. 10.1177/1352458516683266
- By:
- Publication type:
- Article
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0127960
- By:
- Publication type:
- Article
A Hypothesis Test for the End of a Common Source Outbreak.
- Published in:
- Biometrics, 2006, v. 62, n. 1, p. 61, doi. 10.1111/j.1541-0420.2005.00421.x
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsingremitting multiple sclerosis.
- Published in:
- BMC Neurology, 2014, v. 14, n. 1, p. 7, doi. 10.1186/s12883-014-0240-x
- By:
- Publication type:
- Article
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Evaluating Impact of Pulse Pressure on Indexes of Myocardial Work by Speckle-Tracking Echocardiography in Normotensive, Prehypertensive and Newly Diagnosed Hypertensive Patients.
- Published in:
- International Journal of General Medicine, 2022, v. 15, p. 1933, doi. 10.2147/IJGM.S351628
- By:
- Publication type:
- Article
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 1, p. 95, doi. 10.1002/ana.23758
- By:
- Publication type:
- Article
Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 8, p. 1728, doi. 10.1007/s00415-017-8544-6
- By:
- Publication type:
- Article
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
- Published in:
- European Neurology, 2013, v. 70, n. 1/2, p. 35, doi. 10.1159/000346761
- By:
- Publication type:
- Article
Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a.
- Published in:
- International Journal of MS Care, 2016, v. 4, p. 211, doi. 10.7224/1537-2073.2015-042
- By:
- Publication type:
- Article
Disease-Related Determinants of Quality of Life 10 Years After Clinically Isolated Syndrome.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Incidence and risk factors for surgical site infection after open reduction and internal fixation of intra‐articular fractures of distal femur: A multicentre study.
- Published in:
- International Wound Journal, 2019, v. 16, n. 2, p. 473, doi. 10.1111/iwj.13056
- By:
- Publication type:
- Article
Trajectory Planning of Dual-Robot Cooperative Assembly.
- Published in:
- Machines, 2022, v. 10, n. 8, p. 689, doi. 10.3390/machines10080689
- By:
- Publication type:
- Article
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
- Published in:
- Neuroepidemiology, 2015, v. 44, n. 1, p. 16, doi. 10.1159/000369621
- By:
- Publication type:
- Article
A thirst for development: mapping water stress using night-time stable lights as predictors of province-level water stress in China.
- Published in:
- Area, 2017, v. 49, n. 4, p. 477, doi. 10.1111/area.12336
- By:
- Publication type:
- Article
Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCE.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 1, p. 41, doi. 10.1177/1756285616676065
- By:
- Publication type:
- Article
Matching‐adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1087, doi. 10.1111/hae.14818
- By:
- Publication type:
- Article
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 6, p. 2267, doi. 10.1007/s12325-024-02834-9
- By:
- Publication type:
- Article
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Can collaborative innovation constrain ecological footprint? Empirical evidence from Guangdong-Hong Kong-Macao Greater Bay Area, China.
- Published in:
- Environmental Science & Pollution Research, 2022, v. 29, n. 36, p. 54476, doi. 10.1007/s11356-022-19648-3
- By:
- Publication type:
- Article